Developments in virus-like particle-based vaccines for HIV

被引:1
|
作者
Buonaguro, Luigi [1 ]
Tagliamonte, Maria [1 ]
Visciano, Maria Luisa [1 ]
Tornesello, Maria Lina [1 ]
Buonaguro, Franco M. [1 ]
机构
[1] Ist Nazl Tumori Fond Pascale, Dept Expt Oncol, Mol Biol & Viral Oncol Unit, I-80131 Naples, Italy
关键词
baculovirus expression vector system; broadly neutralizing antibody; conformational antigen presentation; HIV-VLPs; insect cells stable expression; vaccines; T-CELL RESPONSES; ANTIGEN-PRESENTING CELLS; ACTIVATE DENDRITIC CELLS; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION PROFILE; TOLL-LIKE RECEPTORS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; CLASS-I; ENVELOPE GLYCOPROTEINS;
D O I
10.1586/ERV.12.152
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Virus-like particles (VLPs) hold great promise for the development of effective and affordable vaccines. VLPs, indeed, are suitable for presentation and efficient delivery to antigen-presenting cells of linear as well as conformational antigens. This will ultimately result in a crosspresentation with both MHC class I and II molecules to prime CD4(+) T-helper and CD8(+) cytotoxic T cells. This review describes an update on the development and use of VLPs as vaccine approaches for HIV.
引用
收藏
页码:119 / 127
页数:9
相关论文
共 50 条
  • [1] Developments in virus-like particle-based vaccines for infectious diseases and cancer
    Buonaguro, Luigi
    Tagliamonte, Maria
    Tornesello, Maria Lina
    Buonaguro, Franco M.
    [J]. EXPERT REVIEW OF VACCINES, 2011, 10 (11) : 1569 - 1583
  • [2] Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
    Chen, Chun-Wei
    Saubi, Narcis
    Joseph-Munne, Joan
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [3] Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
    Gao, Yong
    Wijewardhana, Chanuka
    Mann, Jamie F. S.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] ENGINEERING VIRUS-LIKE PARTICLE-BASED VACCINES FOR CHLAMYDIA TRACHOMATIS
    Stroud, G.
    Chackerian, B.
    Frietze, K.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 113 - 113
  • [5] Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned
    Eto, Yoshiki
    Saubi, Narcis
    Ferrer, Pau
    Joseph, Joan
    [J]. AIDS REVIEWS, 2019, 21 (04) : 218 - 232
  • [6] Virus-like particle-based vaccines against hepatitis C virus infection
    Bellier, Bertrand
    Klatzmann, David
    [J]. EXPERT REVIEW OF VACCINES, 2013, 12 (02) : 143 - 154
  • [7] Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
    Zhang, Naru
    Li, Chaoqun
    Jiang, Shibo
    Du, Lanying
    [J]. VACCINES, 2020, 8 (03) : 1 - 20
  • [8] Overcoming barriers in the mucosal delivery of virus-like particle-based vaccines
    Herbst-Kralovetz, Melissa M.
    [J]. THERAPEUTIC DELIVERY, 2014, 5 (07) : 741 - 744
  • [9] Advances in virus-like particle-based SARS-CoV-2 vaccines
    Hao, Xiaoting
    Yuan, Feifei
    Yao, Xuan
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [10] A NOVEL VIRUS-LIKE PARTICLE-BASED PLATFORM FOR MULTI-ANTIGEN MALARIA VACCINES
    Chan, Jo-Anne
    Wetzel, David
    Andrew, Dean
    Reiling, Linda
    Gilson, Paul
    Anderson, David
    Richards, Jack S.
    Jenzelewski, Volker
    Piontek, Michael
    Beeson, James G.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 130 - 130